Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment

AIMS: To investigate whether the pharmacokinetic characteristics of semaglutide were altered in people with hepatic impairment, assessed using Child–Pugh criteria, vs those with normal hepatic function. METHODS: In this multicentre, open‐label, parallel‐group trial (sponsor Novo Nordisk, ClinicalTri...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Obes Metab
Main Authors: Jensen, Lene, Kupcova, Viera, Arold, Gerhard, Pettersson, Jonas, Hjerpsted, Julie B.
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2018
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5873441/
https://ncbi.nlm.nih.gov/pubmed/29205786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13186
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki